Spelling suggestions: "subject:"βarrestin 2"" "subject:"arrestin 2""
1 |
Involvement of β-Arrestin-2 in Modulation of the Spinal Antinociception Induced by μ-Opioid Receptor Agonists in the MouseOhsawa, Masahiro, Mizoguchi, Hirokazu, Narita, Minoru, Nagase, Hiroshi, Dun, Nae J., Tseng, Leon F. 31 July 2003 (has links)
Beta-arrestins have been suggested to regulate μ-, δ-, and κ-opioid receptor-mediated responses. In the present study, we examined the effects of pretreatment with β-arrestin-2 antibody on tail-flick inhibition induced by opioid receptor agonists in the mouse spinal cord. Intrathecal (i.t.) pretreatment with β-arrestin-2 antibody potentiated the antinociception induced by i.t.-administered μ-opioid receptor agonists [D-Ala2,NMePhe4,Gly-ol5]enkephalin (DAMGO) and endomorphin-1, but not endomorphin-2, the δ-opioid receptor agonist [D-Ala2]deltorphin II or the κ-opioid receptor agonist U50,488H. The present result suggests that β-arrestin-2 may tonically down-regulate a selected population of μ-opioid receptors activated by endomorphin-1 or DAMGO in the mouse spinal cord.
|
2 |
Chronic Stress Promotes Lymphocyte Reduction Through TLR2 Mediated PI3K Signaling in a β-Arrestin 2 Dependent MannerLi, Hui, Chen, Lin, Zhang, Ying, LeSage, Gene, Zhang, Yi, Wu, Yan, Hanley, Gregory, Sun, Shenggang, Yin, Deling 01 April 2011 (has links)
Physical and psychological stress can alter the immune system in both humans and animals. Stress is a known risk factor for numerous human diseases, such as infectious and autoimmune diseases, and cancer. Toll-like receptors (TLRs) play a pivotal role in the induction of innate and adaptive immune response. Our previous studies have shown that TLR4 deficiency prevents stress-induced splenocyte reduction. However, the role of TLR2 in stress-mediated lymphocyte reduction is unknown. In this study, we investigated the effects of TLR2 ligands on stress-induced lymphocyte reduction. We also defined whether the phosphoinositide 3-kinases (PI3Ks)/Akt pathway contributes to TLR2-mediated lymphocyte numbers altered by stress. Our data have shown that stimulation of TLR2 by TLR2 ligands peptidoglycan (PGN) or Pam3CSK4 (Pam3) attenuates stress-induced reduction in lymphocyte numbers. However, TLR2 ligand-induced protection from stress-induced lymphocyte reduction is lost in TLR2 deficiency in mice. Furthermore, stimulation of TLR2 by PGN induces protection from stress-induced reduction in the number of splenocytes through PI3K. Moreover, PGN dramatically increases the level of phosphorylation of Akt through a PI3K-dependent manner. Moreover, we found that stimulation of TLR2 by PGN induced protection from stress-induced reduction in splenocyte numbers is abolished in β-arrestin 2 deficient mice. In addition, PGN-induced immune protection in stress-induced changes of cytokine levels appears to require -arrestin 2, a multifunctional adaptor and signal transducer. Collectively, our study thus demonstrates that stimulation of TLR2-mediated PI3K signaling attenuates splenocyte reduction induced by stress, and that β-arrestin 2 modulates TLR2-mediated immune response following stress.
|
3 |
MicroRNA-155 Attenuates Late Sepsis-Induced Cardiac Dysfunction Through JNK and β-Arrestin 2Zhou, Yu, Song, Yan, Shaikh, Zahir, Li, Hui, Zhang, Haiju, Caudle, Yi, Zheng, Shouhua, Yan, Hui, Hu, Dan, Stuart, Charles, Yin, Deling 01 January 2017 (has links)
Cardiac dysfunction is correlated with detrimental prognosis of sepsis and contributes to a high risk of mortality. After an initial hyperinflammatory reaction, most patients enter a protracted state of immunosuppression (late sepsis) that alters both innate and adaptive immunity. The changes of cardiac function in late sepsis are not yet known. MicroRNA-155 (miR-155) is previously found to play important roles in both regulations of immune activation and cardiac function. In this study, C57BL/6 mice were operated to develop into early and late sepsis phases, and miR-155 mimic was injected through the tail vein 48 h after cecal ligation and puncture (CLP). The effect of miR-155 on CLP-induced cardiac dysfunction was explored in late sepsis. We found that increased expression of miR-155 in the myocardium protected against cardiac dysfunction in late sepsis evidenced by attenuating sepsis-reduced cardiac output and enhancing left ventricular systolic function. We also observed that miR-155 markedly reduced the infiltration of macrophages and neutrophils into the myocardium and attenuated the inflammatory response via suppression of JNK signaling pathway. Moreover, overexpression of β-arrestin 2 (Arrb2) exacerbated the mice mortality and immunosuppression in late sepsis. Furthermore, transfection of miR-155 mimic reduced Arrb2 expression, and then restored immunocompetence and improved survival in late septic mice. We conclude that increased miR-155 expression through systemic administration of miR-155 mimic attenuates cardiac dysfunction and improves late sepsis survival by targeting JNK associated inflammatory signaling and Arrb2 mediated immunosuppression.
|
4 |
β-arrestin 2 Attenuates Cardiac Dysfunction in Polymicrobial Sepsis Through gp130 and p38Yan, Hui, Li, Hui, Denney, James, Daniels, Christopher, Singh, Krishna, Chua, Balvin, Stuart, Charles, Caudle, Yi, Hamdy, Ronald, LeSage, Gene, Yin, Deling 01 September 2016 (has links)
Sepsis is an exaggerated systemic inflammatory response to persistent bacteria infection with high morbidity and mortality rate clinically. β-arrestin 2 modulates cell survival and cell death in different systems. However, the effect of β-arrestin 2 on sepsis-induced cardiac dysfunction is not yet known. Here, we show that β-arrestin 2 overexpression significantly enhances animal survival following cecal ligation and puncture (CLP)-induced sepsis. Importantly, overexpression of β-arrestin 2 in mice prevents CLP-induced cardiac dysfunction. Also, β-arrestin 2 overexpression dramatically attenuates CLP-induced myocardial gp130 and p38 mitogen-activated protein kinase (MAPK) phosphorylation levels following CLP. Therefore, β-arrestin 2 prevents CLP-induced cardiac dysfunction through gp130 and p38. These results suggest that modulation of β-arrestin 2 might provide a novel therapeutic approach to prevent cardiac dysfunction in patients with sepsis.
|
5 |
Β-Arrestin 2-Mediated Immune Suppression Induced by Chronic StressLi, Hui, Smalligan, Dean A., Xie, Nanchang, Javer, Avani, Zhang, Yi, Hanley, Gregory, Yin, Deling 01 March 2011 (has links)
Objective: Stress, either physical or psychological, can modulate immune function. However, the mechanisms associated with stress-induced immune suppression remain to be elucidated. β-Arrestin 2 serves as adaptor, scaffold, and/or signal transducer. The role of β-arrestin 2 in stress-induced immune suppression is not known yet. Methods/Results: Here, we demonstrate that β-arrestin 2 deficiency in mice increases the sensitivity to the chronic stress-induced reduction in the number of splenocytes. Interestingly, the stress-induced suppression of T helper-type (Th) 1 cytokines and the increased production of Th2 cytokines were greatly enhanced in β-arrestin 2-deficient mice compared with wild-type mice. Moreover, inhibition of PI3K in β-arrestin 2-deficient mice exerts an additive effect on the stress-induced reduction in the number of splenocytes. Conclusion: Our study demonstrates that a deficiency in β-arrestin 2 augments stress-induced immune suppression.
|
6 |
Beta-Arrestin 2 Modulates Resveratrol-Induced Apoptosis and Regulation of Akt/GSK3β PathwaysSun, Xiuli, Zhang, Yi, Wang, Jianliu, Wei, Lihui, Li, Hui, Hanley, Gregory, Zhao, Miaoqing, Li, Yi, Yin, Deling 01 September 2010 (has links)
Background: Resveratrol is emerging as a novel anticancer agent. However, the mechanism(s) by which resveratrol exerts its effects on endometrial cancer (EC) are unknown. We previously reported that β-arrestin 2 plays a critical role in cell apoptosis. The role of β-arrestin 2 in resveratrol modulation of endometrial cancer cell apoptosis remains to be established. Scope of Review: EC cells HEC1B and Ishikawa were transfected with either β-arrestin 2 RNA interfering (RNAi) plasmid or β-arrestin 2 full-length plasmid and control vector. The cells were then exposed to differing concentrations of resveratrol. Apoptotic cells were detected by TUNEL assay. Expression of total and phosphorylated Akt (p-Akt), total and phosphorylated glycogen synthase kinase 3 beta (p-GSK3β), and caspase-3 were determined by Western blot analysis. Our data demonstrate that inhibition of β-arrestin 2 increases the number of apoptotic cells and caspase-3 activation. Additionally β-arrestin 2 exerted an additive effect on resveratrol-reduced levels of p-Akt and p-GSK3β. Overexpression of β-arrestin 2 decreased the percentage of apoptosis and caspase-3 activation and attenuated resveratrol-reduced levels of p-Akt and p-GSK3β. Taken together, our studies demonstrate for the first time that β-arrestin 2 mediated signaling plays a critical role in resveratrol-induced apoptosis in EC cells. Major Conclusions: Resveratrol primes EC cells to undergo apoptosis by modulating β-arrestin 2 mediated Akt/GSK3β signaling pathways. General significance: These inspiring findings would provide a new molecular basis for further understanding of cell apoptotic mechanisms mediated by β-arrestin 2 and may provide insights into a potential clinical relevance in EC.
|
7 |
Morphine Promotes Apoptosis via TLR2, and This Is Negatively Regulated by β-Arrestin 2Li, Yi, Sun, Xiu L., Zhang, Yi, Huang, Jing J., Hanley, Gregory, Ferslew, Kenneth E., Peng, Ying, Yin, De Ling 23 January 2009 (has links)
We have previously reported that morphine induces apoptosis. However, the underlying molecular mechanisms remain to be elucidated. Toll-like receptor 2 (TLR2), a key immune receptor in the TLR family, modulates cell survival and cell death in various systems. Evidence indicates that β-arrestin 2 acts as a negative regulator of innate immune activation by TLRs. Here, we investigated the roles of TLR2, the downstreaming mediator MyD88, and β-arrestin 2 in morphine-induced apoptosis. We showed that overexpression of TLR2 in HEK293 cells caused a significant increase in apoptosis after morphine treatment. Inhibition of MyD88 by transfecting dominant negative MyD88 or overexpression of β-arrestin 2 by transfecting β-arrestin 2 full length plasmid in TLR2 overexpressing HEK293 cells attenuated morphine-induced apoptosis. Our study thus demonstrates that TLR2 signaling mediates the morphine-induced apoptosis, and β-arrestin 2 is a negative regulator in morphine-induced, TLR2-mediated apoptosis.
|
8 |
Β-Arrestin 2 Regulates Toll-Like Receptor 4-Mediated Apoptotic Signalling Through Glycogen Synthase Kinase-3βLi, Hui, Sun, Xiuli, Lesage, Gene, Zhang, Yi, Liang, Zhihou, Chen, Jixiang, Hanley, Gregory, He, Lei, Sun, Shenggang, Yin, Deling 01 August 2010 (has links)
Toll-like receptor 4 (TLR4), a key member of the TLR family, has been well characterized by its function in the induction of inflammatory products of innate immunity. However, the involvement of TLR4 in a variety of apoptotic events by an unknown mechanism has been the focus of great interest. Our investigation found that TLR4 promoted apoptotic signalling by affecting the glycogen synthase kinase-3β (GSK-3β) pathway in a serum-deprivation- induced apoptotic paradigm. Serum deprivation induces GSK-3β activation in a pathway that leads to subsequent cell apoptosis. Intriguingly, this apoptotic cascade is amplified in presence of TLR4 but greatly attenuated by β-arrestin 2, another critical molecule implicated in TLR4-mediated immune responses. Our data suggest that the association of β-arrestin 2 with GSK-3β contributes to the stabilization of phospho-GSK-3β, an inactive form of GSK-3β. It becomes a critical determinant for the attenuation of TLR4-initiated apoptosis by β-arrestin 2. Taken together, we demonstrate that the TLR4 possesses the capability of accelerating GSK-3β activation thereby deteriorating serum-deprivation-induced apoptosis; β-arrestin 2 represents an inhibitory effect on the TLR4-mediated apoptotic cascade, through controlling the homeostasis of activation and inactivation of GSK-3β.
|
9 |
Regulation of the Dopamine D3 Receptor by Adenylyl Cyclase 5Habibi Khorasani, Hedieh 10 May 2022 (has links)
The D3 dopamine receptor (D3R) belongs to D2-class of dopamine receptors (DARs) and is
involved in emotion, movement, and reward. D3R dysfunction has been reported in some
neuropsychiatric disorders such as addiction, cognitive deficits, depression, schizophrenia, and
Parkinson’s disease. Genetic studies have shown two polymorphic variants of the D3R gene
resulting from substitution of serine to glycine at position nine of the amino terminus. Isoform
5 of adenylyl cyclase (AC5) is one of the nine transmembrane bound ACs in the brain and
myocardium. Previous studies in rats have shown that AC5 is expressed in the striatum, nucleus
accumbens and olfactory tubercle and at lower levels in islands of Calleja, where the D3R is
also expressed. Previous studies showed that although D2R and D4R inhibit ACs activity in
different cell types, inhibition of ACs by D3R is weak and often undetectable. It has been
shown that D3R selectively inhibits AC5 activity in human embryonic kidney 293 (HEK293)
cells co-transfected with D3R and AC5. Co-expression of D3R and AC5 in brain regions which
are major coordinators of normal and pathological movement, and the selective inhibition of
AC5 activity by D3R raise the possibility of a functional link between AC5 and D3R in the
modulation of signal transduction and trafficking. I hypothesized that AC5 plays a unique role
in modulation of D3R trafficking and signaling pathways through interaction between D3R
and AC5. Herein, I demonstrated an interaction between D3R and AC5 in vivo and in vitro
using reciprocal co-immunoprecipitation/immunoblotting (co-IP/IB) assays. Interestingly, DA
may facilitate the formation of protein complex between D3R and AC5 in vitro. Radio ligand
binding assays revealed that heterodimerization of D3R polymorphic variants with AC5 does
not change ligand binding affinity and expression of the D3R. Furthermore, taking advantages
of GloSensor assays, selective inhibition of AC5 activity by D3Ser9 and D3Gly9 has been
shown following activation by DA and quinpirole. Using ELISA studies showed that AC5
promotes cell surface expression and total expression of D3Ser9 and D3Gly9. Moreover, ELISA results suggested that AC5 facilitates DA-induced D3Ser9 endocytosis in dynamin and
β-arrestin 2 dependent process, while having no effect on D3Gly9 polymorphic variant. The
results also revealed that AC5 attenuates heterologous (PKC-induced) internalization of
D3Ser9, while it does not have any effect on D3Gly9 heterologous internalization. My results
also displayed a complex formation between D3R, AC5 and, β-arrestin 2 under basal and DA
stimulation conditions, which emphasize the role of β-arrestin 2 in D3R signal transduction.
Overall, a new regulatory mechanism for D3R has been suggested. My results suggested that
complex formation between both D3R polymorphic variants with AC5 can regulate signaling
and trafficking properties of D3R without changing the binding affinity of the receptor. These
data will be meaningful for understanding of diseases and developing treatment strategies.
|
Page generated in 0.0699 seconds